Starting in 2026, Belize will implement a long-planned update to the nation’s prescription drug regulations, developed through close collaboration between the Pharmacists Association of Belize and the country’s Ministry of Health. With public anxiety growing over potential access disruptions to essential medications, particularly for patients managing long-term chronic conditions, industry representatives have moved quickly to clarify that the reform is focused on patient safety, not limiting access to care.
The two governing bodies have agreed to a 12-month phased rollout of the updated rules, a transition period designed to gradually shift Belize’s healthcare culture toward greater medical accountability and routine health monitoring. Speaking on behalf of the association, Public Relations Officer Beverly Coleman explained that while formal prescription requirements have existed in national law for decades, widespread non-compliance and a lack of routine patient follow-up care created the need for a gradual transition. Many patients in Belize have long become accustomed to refilling long-term medications without regular check-ins with physicians or routine lab work to monitor how medications are affecting their health, she noted.
“Any substance we put into our bodies — from over-the-counter pain relievers like Tylenol to herbal supplements — carries potential impacts that need medical oversight,” Coleman explained during an interview following the announcement. During the 12-month transition, pharmacists will be permitted to dispense limited one-month supplies of medication to give patients time to schedule required check-ups and get formal prescriptions from their doctors. Coleman emphasized the transition is not an unregulated free-for-all, but a structured opportunity for all stakeholders — doctors, pharmacists and patients — to adjust to the new safety standards.
As the rollout approaches, however, concerns have emerged about strain on Belize’s already stretched healthcare system. Officials project that a surge of patients will flood primary care clinics to obtain required new prescriptions, raising questions about how gaps in care can be addressed, particularly in rural and geographically isolated underserved regions of the country. Discussion has turned to whether expanding prescribing authority to pharmacists could help ease the added pressure on clinics.
Currently, Belizean law strictly limits pharmacists’ scope of practice: pharmacists are only permitted to dispense medications written by licensed physicians, and are tasked with flagging potential issues such as dangerous drug interactions or incorrect dosages to prescribing clinicians. Coleman confirmed that expanding this scope to allow limited prescribing by pharmacists for simple or stable chronic conditions is a topic that will be negotiated with the Ministry of Health in the coming months, given Belize’s unique geographic context where many remote communities lack consistent access to physicians.
“Medicine is a constantly evolving field, and pharmacists must stay updated on the latest research to properly educate and counsel our patients,” Coleman added. She noted that any change to professional scope will require careful legislative negotiation and alignment with public health needs, to ensure patient safety remains the core priority as the system adapts.